IntroductionAcromegaly is a quite rare chronic disease caused by the increased secretion of growth hormone (GH) and subsequently insulin - like growth factor 1. Although cardiovascular diseases remains the most common cause of mortality among acromegalic patients, increased prevalence of malignant and benign neoplasms remains a matter of debate. The aim of this study is to evaluate the risk of thyroid nodular disease (TND) and thyroid cancer in patients with acromegaly.Materials and MethodsPubMed, Cochrane Library, Scopus, Cinahl, Academic Search Complete, Web of Knowledge, PubMed Central, PubMed Central Canada and Clinical Key databases were searched to identify studies containing. Random–effects model was used to calculate pooled odds ratios and risk ratios of TND in acromegaly. Studies which not included control groups were systematically reviewed.ResultsTND was more frequent in acromegaly than in control groups (OR = 6.9, RR = 2.1). The pooled prevalence of TND was 59.2%. Also thyroid cancer (TC) proved to be more common in acromegalic patients (OR = 7.5, RR = 7.2), prevalence was 4.3%. The pooled rate of malignancy (calculated per patient) was equal to 8.7%.ConclusionsThis study confirms that both TND and TC occur significantly more often in acromegalic patients than in general population. These results indicate that periodic thyroid ultrasound examination and careful evaluation of eventual lesions should be an important part of follow-up of patients with acromegaly.

IntroductionThyroid nodular disease (TND) is a very common disorder. However, since the rate of malignancy is reported to be 3-10%, only a minority of patients require aggressive surgical treatment. As a result, there is a need for diagnostic tools which would allow for a reliable differentiation between benign and malignant nodules. Although a number of conventional ultrasonographic (US) features are proved to be markers of malignancy, Shear Wave Elastography (SWE) is considered to be an improvement of conventional US. The aim of this study was to compare conventional US markers and SWE diagnostic values in the differentiation of benign and malignant thyroid nodules.Materials and MethodsAll patients referred for thyroidectomy, irrespective of the indications, underwent a US thyroid examination prospectively. Patients with TND were included into the study. Results of the US and SWE examinations were compared with post-surgical histopathology. ResultsOne hundred and twenty two patients with 393 thyroid nodules were included into the study. Twenty two patients were diagnosed with cancer. SWE turned out to be a predictor of malignancy superior to any other conventional US markers (OR=54.5 using qualitative scales and 40.8 using quantitative data on maximal stiffness with a threshold of 50 kPa). ConclusionsAlthough most conventional US markers of malignancy prove to be significant, none of them are characterized by both high sensitivity and specificity. SWE seems to be an important step forward, allowing for a more reliable distinction of benign and malignant thyroid nodules. Our study, assessing SWE properties on the highest number of thyroid lesions at the time of publication, confirms the high diagnostic value of this technique. It also indicates that a quantitative evaluation of thyroid lesions is not superior to simpler qualitative methods.

No abstract

Cannabinoids are the derivatives of the cannabis plant, the most potent bioactive component of which is tetrahydrocannabinol (THC). The most commonly used drugs containing cannabinoids are marijuana, hashish, and hashish oil. These compounds exert their effects via interaction with the cannabinoid receptors CB1 and CB2. Type 1 receptors (CB1) are localised mostly in the central nervous system and in the adipose tissue and many visceral organs, including most endocrine organs. Type 2 cannabinoid receptors (CB2) are positioned in the peripheral nervous system (peripheral nerve endings) and on the surface of the immune system cells. Recently, more and more attention has been paid to the role that endogenous ligands play for these receptors, as well as to the role of the receptors themselves. So far, endogenous cannabinoids have been confirmed to participate in the regulation of food intake and energy homeostasis of the body, and have a significant impact on the endocrine system, including the activity of the pituitary gland, adrenal cortex, thyroid gland, pancreas, and gonads. Interrelations between the endocannabinoid system and the activity of the endocrine system may be a therapeutic target for a number of drugs that have been proved effective in the treatment of infertility, obesity, diabetes, and even prevention of diseases associated with the cardiovascular system. (Endokrynol Pol 2018; 69 (6): 705-719)

Elastography is a method of tissue stiffness assessment. It has already been demonstrated that thyroid cancers are less elastic than benign lesions. However, little is known about other factors, which might influence the stiffness of thyroid nodules and disrupt the prediction of malignancy using this technique. The aim of this study was to conduct the first systematic assessment of factors potentially affecting the elasticity of thyroid lesions. One hundred and twenty-two patients with thyroid nodular disease admitted for thyroidectomy underwent preoperative ultrasonography and sonoelastography. The definite diagnosis of thyroid lesions was based on histological examination. What was evaluated in the study was the influence of composition, size, localization, nodularity, and selected laboratory parameters on thyroid nodule elasticity. Firstly, association between the above-mentioned factors and elasticity was assessed in benign lesions. Secondly, all nodules (benign and malignant) were divided into subgroups according to the presence or absence of particular features, which turned out to be an important disturbing factor increasing the stiffness of the lesion in the first step of analysis. There were 22 malignant and 371 benign lesions. The analysis of benign lesions revealed that the presence calcifications (p < 0.0001) significantly increased nodule stiffness. Partially, cystic nodules were significantly less elastic than solid ones (p = 0.03). There was also positive correlation between nodule size and stiffness (p < 0.0001). Lesions localized in the isthmus were significantly less elastic than nodules in other localizations. (p = 0.0001). Solitary nodules were less elastic than lesions in multinodular goiter (p = 0.006). Correlation between Tg concentration and stiffness was significant (p < 0.0001, r = 0.24). The concentration of anti-thyroid autoantibodies was associated with stiffness at the border of significance. However, there was no significant difference between benign lesions in patients with diagnosed chronic autoimmune thyroiditis and patients without the disease. The analysis of the entire group of nodules revealed that shear wave elastography is a valuable modality of thyroid nodule assessment, with sensitivity of over 95 % and specificity of about 70 %. However, the stiffness value of the lesion might be increased in the case of nodules containing calcifications, cystic component, and those of size above 20 mm. Certain clinical conditions or attributes of the lesions influence the stiffness values of thyroid nodules. Identifying these variables is the basis for a credible interpretation of the results of a sonoelastographic examination and makes it possible to estimate the risk of thyroid nodule malignancy adequately.